MetaCap

PetMed Express Inc. (PETS)

NASDAQ: PETSConsumer StaplesRetail-Drug Stores and Proprietary StoresUSD

0.8501-0.0743 (-8.04%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

PETS stock chart

Technical analysis

Key statistics

All statistics
Market cap
$18.90M
EPS (TTM)
-$1.29
Ex-dividend date
Aug 11, 2023
52-week range
0.8466 – 4.10
Day range
0.8466 – 0.9115
Volume / Avg
115.65K / 118.20K
Beta
—

52-week range

$0.8466$4.10

PETS stock today

PetMed Express (PETS) closed at $0.8501 on Nov 20, down 8.04% (-$0.0743), versus the S&P 500's 3.70% decline. At this level, PETS sits near the bottom of its 52-week range of $0.8466 to $4.10: 79.3% below the high, set on Dec 16, 2025 and 0.4% above the low. PETS is down 73.4% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 47.2%.

PetMed Express has posted a net loss over the last twelve months (EPS of -$1.29), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About PetMed Express

Company profile

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.

Industry
Retail-Drug Stores and Proprietary Stores
CEO
Ms. Leslie C. G. Campbell
Headquarters
Delray Beach, FL
Employees
189

Financial highlights

Full financials

In fiscal 2026, PetMed Express generated $179.0 million in revenue, down 21.1% from fiscal 2025, its first annual decline since 2025. PetMed Express reported a net loss of $57.3 million, compared with a loss of $6.3 million a year earlier. Gross margin was 28.1% (down from 30.5%) and operating margin -32.8%.

PetMed Express annual revenue, net income and EPS
Fiscal yearFY 2026FY 2025FY 2024FY 2023FY 2022
Revenue$179.02M$226.97M$274.10M$247.57M$272.28M
Growth-21.13%-17.19%+10.71%-9.08%-10.31%
Net income$-57.29M$-6.27M$-7.46M$5.14M$18.72M
EPS (diluted)$-2.74$-0.30$-0.37$0.25$0.92

Analyst forecast

Forecast

Consensus (1 analysts)

sell

Avg. price target

$1.40+64.69%

  • Strong buy 0
  • Buy 0
  • Hold 0
  • Sell 1
  • Strong sell 0

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 10, 2026
EPS actual vs est.
$-0.31 vs $-0.11
Surprise
-181.82%

Dividends

Dividend history
Annual dividend
$0.00
Last payment
$0.30
Ex-dividend date
Aug 11, 2023

PETS news

All PETS news

PetMed Express peers

Consumer Staples sector
PETS peer companies
CompanyPrice% ChgMarket capCompare
YI111 Inc. ADR2.36-5.98%$20.76Mvs PETS
RDGTRidgetech Inc.0.94-7.44%$3.41Mvs PETS
GRDNGuardian Pharmacy Services Inc. Class A46.94+0.58%$2.97Bvs PETS
CVSCVS Health Corporation80.84+1.00%$103.43Bvs PETS

Indexes, lists and sector

PetMed Express stock FAQ

What is PetMed Express's stock price today?

PETS last traded at $0.8501 as of Nov 20, 4:00 PM EST, down 8.04% on the day. Prices are delayed at least 15 minutes.

Does PetMed Express pay a dividend?

Yes. PetMed Express pays $0.00 per share annually. The most recent dividend of $0.30 had an ex-dividend date of Aug 11, 2023.

Who is PetMed Express's CEO?

Ms. Leslie C. G. Campbell is the chief executive officer of PetMed Express Inc., which has about 189 employees.

What is the PETS 52-week high?

The 52-week high for PETS is $4.10 and the 52-week low is $0.8466. The stock is currently 79.3% below its high.

Compare PETS